Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy ...
Jul 9, 2014
1
0